Mortality reduction in pediatric patients with severe fatal human adenoviral pneumonia treated with high titer neutralizing antibodies (NAbs) plasma: a retrospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "BMC Pediatrics"
DOI: 10.1186/s12887-022-03225-1
Abstract: Background Severe fatal human adenoviral (HAdV) pneumonia is associated with significant mortality and no effective drug is available for clinical therapy. We evaluated the association and safety of high titer neutralizing antibodies (NAbs) plasma in… read more here.
Keywords: nabs plasma; high titer; severe fatal; mortality ... See more keywords